Brief: Syros Pharmaceuticals Files Prospectus Relates To Resale From Time To Time Of Up To 27.6 Mln Shares Of Common Stock By Selling Stockholders
14/10/2022 22:20
Oct 14 (Reuters) - Syros Pharmaceuticals Inc SYRS.O :
* SYROS PHARMACEUTICALS INC FILES PROSPECTUS RELATES TO
RESALE
FROM TIME TO TIME OF UP TO 27.6 MILLION SHARES OF COMMON STOCK
BY SELLING STOCKHOLDERS
Further company coverage: SYRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial